Oren Pasvolsky

Oren Pasvolsky is a Senior Professor at The University of Texas MD Anderson Cancer Center, specializing in hematology and oncology. His research focuses on hematological malignancies, immunology, and cellular therapy, with particular emphasis on stem cell and bone marrow transplantation. His latest work investigates CAR T-cell therapy in multiple myeloma, including immune effector cell enteritis/colitis driven by persistent clonal CAR+ T-cells, early relapse prediction through minimal residual disease monitoring, and risk-adapted therapy design. He has also explored genetic ancestry's impact on outcomes of idecabtagene vicleucel and identified modifiable risk factors for delayed neurotoxicity in relapsed myeloma patients. His recent publications appear in Transplantation and Cellular Therapy and Blood Cancer Journal.